LUMBY, British Columbia, Jan. 16 /PRNewswire-FirstCall/ -- avVaa World Health Care Products, Inc. , a biotech company offering global customers therapeutic skin and health care products, is pleased to announce it has filed its SEC form 10-QSB quarterly report containing financial and operating results for the three months ended November 30, 2006.
For the second quarter of FY07, avVaa reports a loss for the three months ended November 30, 2006 of $1,277,363 ($0.02 per share) as compared to a loss of $832,573 reported for the comparable three months ended November 30, 2005 ($0.02 per share).
avVaa World Health Care Products Interim CEO Darrell Stevens said, “As we remain committed to the potential of our unique skin and health care lines for today’s consumers, we are pleased with the initial results of research and sales and marketing campaigns.”
Stevens continued, “In the coming months, we will continue to target effective distribution and sales campaigns, coupled with on-going research and development in support of avVaa ‘s primary and secondary care products.”
This press release briefly summarizes only certain portions of the Company’s Quarterly Report on Form 10-QSB for the three months ended for November 30, 2006, and readers should review the entire report filed with the SEC, available at www.sec.gov.
About avVaa World Health Care Products
avVaa World Health Care Products is a global biotechnology company that specializes in effective, therapeutic human skin care and animal care products that improve quality of life and well being for consumers. avVaa’s patented European skin care formulas are scientifically registered, FDA-Compliant, and were developed to relieve and treat the symptoms of dermatitis, psoriasis and acne. avVaa is poised to manufacture and market its OTC NEUROSKIN line of skin care products through mass, food and drug channels in the United States and globally.
The Company’s second generation of its unique, high-quality therapeutic skin care products includes a comprehensive line of Animal Care products designed to capture share of the $44 billion+ worldwide animal care and products market. avVaa sells its quality Animal Care products through partnerships with established distributors and retailers in both Canada and the United States.
For additional information on avVaa, contact Jack Farley CEO / Chairman, at 1-866-772-8822 or visit: www.avvaa.com or www.otcfn.com/avvw.
CONTACT: Investor Relations, Merle Goertz (West Coast) of avVaa WorldHealth Care Products, 1-604-688-2349; or Rick McCaffrey of OTC Financial Network, 1-781-444-6100 ext. 625.
Statements contained in this press release that are not based upon current or historical fact are forward looking in nature. Such forward-looking statements are subject to risks and uncertainties, which could cause actual results to differ materially from estimated results. Management cautions that all statements as to future results of operations are necessarily subject to risks, uncertainties, and events that may be beyond the control of AVVAA World Health Care Products, Inc. and no assurance can be given that such results will be achieved. Potential risks and uncertainties include but are not limited to the ability to procure, properly price, retain, and successfully complete projects, the availability of technical personnel, changes in technology, and competition.
avVaa World Health Care Products
CONTACT: Jack Farley CEO - Chairman of avVaa World Health Care Products,+1-866-772-8822; or Investor Relations, Merle Goertz (West Coast) of avVaaWorldHealth Care Products, +1-604-688-2349, or Rick McCaffrey of OTCFinancial Network, 1-781-444-6100 ext. 625, for avVaa World Health CareProducts
Web site: http://www.avvaa.com//
